Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Submitted by
admin
on March 29, 2018 - 10:01am
Source:
Reuters
News Tags:
Teva Pharmaceutical
GSK
patents
Coreg
Headline:
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Do Not Allow Advertisers to Use My Personal information
